Sunday, September 25, 2022



Contact us 561.316.3330



As CBD Use Rises, Clinical Trials Needed to Determine Safety, Efficacy in Heart Disease Patients

A review of existing studies found ( CBD ) no clinical recommendations can be made given current evidence. ACC Latin America 2022 Together with CardioAcademic will be held in Mexico City on September 9-10, 2022.

Monkeypox Has Potential to Cause Heart Problems

A 31-year-old male with confirmed monkeypox infection developed acute myocarditis approximately one week following the onset of monkeypox symptoms

ACC Latin America 2022 Together with CardioAcademic Focuses on Global Collaboration

ACC Vice President B. Hadley Wilson, MD, FACC, executive vice-chair at the Sanger Heart & Vascular Institute, and ACC Assembly of International Governors Past Chair Erick Alexanderson, MD, FACC, chairman of the Nuclear Cardiology Department at the Instituto Nacional de Cardiología "Ignacio Chávez" and director of CardioAcademic, will serve as co-chairs for the conference.

ACC, AHA Issue Updated Chest Pain Data Standards

The 2021 American Heart Association/American College of Cardiology Guideline for the Evaluation and Diagnosis of Chest Pain underscored the need to reach a consensus for the definitions of chest pain.

ACC Issues Guidance to Address New Nonstatin Therapies

The 2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Diseases Risk will publish online in the Journal of the American College of Cardiology on Thursday, August 25, 2022, at 2:00 p.m. ET. It was endorsed by the National Lipid Association.

Smaller Airways Increase COPD Risk for Women

Overall, men have a higher rate of diagnosis and mortality, but with changes in smoking behavior and increasing urbanization, the prevalence of COPD risk for women is on the rise.

By using this website you agree to accept Medical Device News Magazine Privacy Policy